Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Prostatic Neoplasms 9Colorectal Neoplasms 5Breast Neoplasms 5Neoplasms 4Small Cell Lung Carcinoma 3Lung Neoplasms 3Urinary Bladder Neoplasms 2Stomatitis 2Rectal Neoplasms 2Precancerous Conditions 2Male Urogenital Diseases 2Head and Neck Neoplasms 2Colonic Neoplasms 2Cardiovascular Diseases 2Carcinoma, Non-Small-Cell Lung 2Vascular Diseases 1Ulcer 1Thrombocytopenia 1Squamous Cell Carcinoma of Head and Neck 1Sexual Dysfunction, Physiological 1Radiation-induced Injuries in Patients With Rectal Cancer 1Radiation Injuries 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Non-melanoma Skin Cancer 1Neurotoxicity Syndromes 1Myocardial Ischemia 1

Interventions

Paclitaxel 326Carboplatin 318Bevacizumab 167Gemcitabine 106pembrolizumab 101liposomal doxorubicin 100Cyclophosphamide 96Topotecan 93Cisplatin 89olaparib 86niraparib 60Docetaxel 56Taxes 52Doxorubicin 50Drug Therapy 42fludarabine 40Filgrastim 39Nivolumab 37Etoposide 32Specimen Handling 31Magnetic Resonance Spectroscopy 29Immunoglobulin G 27Disulfides 27Peripheral Blood Stem Cell Transplantation 26Albumin-Bound Paclitaxel 25durvalumab 24aldesleukin 24Hyperthermic Intraperitoneal Chemotherapy 24Oxaliplatin 23Biopsy 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Ovarian Neoplasms × Vitamin E × Clear all
NCT00228319 2018-06-19

Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants

University of Kansas Medical Center

Phase 1/2 Completed
27 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡